Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
about
Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity.Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget.Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade.Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer.The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer.A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.
P2860
Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
@ast
Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
@en
type
label
Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
@ast
Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
@en
altLabel
Sphingosine kinase inhibitors: a review of patent literature (2006-2015)
@en
prefLabel
Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
@ast
Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
@en
P2093
P2860
P921
P1476
Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
@en
P2093
Kevin R Lynch
S Brandon Thorpe
Webster L Santos
P2860
P304
P356
10.1080/13543776.2016.1226282
P407
P577
2016-08-19T00:00:00Z